Dudediligence.

NeOnc Technologies Holdings, Inc

NTHINASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

25.9M

on 2026-06-30, from 19.0M on 2025-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2026-04-02. 1 prospectus supplement filed under it since. S-3 ↗

$75.0M

Agreement of 2026-04-10. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-10 is not read yet.

Cash

0.4 quarters

$2.0M on 2026-06-30 ÷ $5.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-09-08Registered direct offering incl. 0.96M pre-funded3,571,430$4.20$15.0M424B5 ↗
2026-06-10Private placementnot read$833.34not stated8-K ↗
2025-11-13Public offeringnot readnot readnot read424B4 ↗
2025-06-16Public offeringnot readnot readnot read424B5 ↗
2025-03-26Private placementnot read$16.00$1.6M8-K ↗

Also on file: $5.0M convertible notes, 2025-07-16 8-K ↗